Dimensional Fund Advisors
INFI

Dimensional Fund Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Dimensional Fund Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$16K Sell
13,057
-37,775
-74% -$40.7K ﹤0.01% 3472
2022
Q2 		$32K Sell
50,832
-4,997
-9% -$3.84K ﹤0.01% 3428
2022
Q1 		$64K Buy
55,829
+2,860
+5% +$3.42K ﹤0.01% 3441
2021
Q4 		$119K Sell
52,969
-13,100
-20% -$32.9K ﹤0.01% 3414
2021
Q3 		$226K Sell
66,069
-36,642
-36% -$113K ﹤0.01% 3330
2021
Q2 		$307K Buy
+102,711
New +$325K ﹤0.01% 3251
2020
Q4 		– Sell
-295,795
Closed -$346K – 3367
2020
Q3 		$346K Sell
295,795
-597,526
-67% -$614K ﹤0.01% 3128
2020
Q2 		$808K Sell
893,321
-97,264
-10% -$92.7K ﹤0.01% 2991
2020
Q1 		$830K Hold
990,585
– – ﹤0.01% 2954
2019
Q4 		$951K Sell
990,585
-80,869
-8% -$88.7K ﹤0.01% 3017
2019
Q3 		$1.1M Hold
1,071,454
– – ﹤0.01% 2988
2019
Q2 		$1.93M Sell
1,071,454
-19,865
-2% -$32K ﹤0.01% 2914
2019
Q1 		$2.05M Sell
1,091,319
-9,766
-0.9% -$14.3K ﹤0.01% 2895
2018
Q4 		$1.3M Buy
1,101,085
+35,211
+3% +$63.3K ﹤0.01% 2961
2018
Q3 		$2.89M Buy
1,065,874
+133,504
+14% +$276K ﹤0.01% 2833
2018
Q2 		$1.78M Buy
932,370
+198,098
+27% +$400K ﹤0.01% 2913
2018
Q1 		$1.54M Buy
734,272
+317,583
+76% +$681K ﹤0.01% 2913
2017
Q4 		$846K Buy
416,689
+325,736
+358% +$676K ﹤0.01% 3020
2017
Q3 		$121K Sell
90,953
-561,528
-86% -$697K ﹤0.01% 3259
2017
Q2 		$1.02M Buy
652,481
+160,814
+33% +$310K ﹤0.01% 2975
2017
Q1 		$1.59M Buy
+491,667
New +$1.21M ﹤0.01% 2881
2015
Q4 		– Sell
-247,069
Closed -$2.09M – 3351
2015
Q3 		$2.09M Sell
247,069
-138,868
-36% -$1.28M ﹤0.01% 2810
2015
Q2 		$4.22M Sell
385,937
-4,713
-1% -$60.5K ﹤0.01% 2622
2015
Q1 		$5.46M Hold
390,650
– – ﹤0.01% 2524
2014
Q4 		$6.6M Hold
390,650
– – ﹤0.01% 2451
2014
Q3 		$5.24M Sell
390,650
-15,058
-4% -$179K ﹤0.01% 2531
2014
Q2 		$5.17M Buy
405,708
+31,573
+8% +$329K ﹤0.01% 2555
2014
Q1 		$4.45M Sell
374,135
-3,638
-1% -$48.8K ﹤0.01% 2599
2013
Q4 		$5.22M Sell
377,773
-9,566
-2% -$135K ﹤0.01% 2537
2013
Q3 		$6.76M Sell
387,339
-118,292
-23% -$2.27M 0.01% 2390
2013
Q2 		$8.22M Buy
+505,631
New +$15.6M 0.01% 2175

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Dimensional Fund Advisors's INFI Position: Q3 2022 in Review

Dimensional Fund Advisors reduced its Infinity Pharmaceuticals, Inc. (INFI) stake by 74% in Q3 2022, selling an estimated $40.7K and leaving 13,057 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #3472.

Dimensional Fund Advisors first reported a position in INFI in Q2 2013 and has held it in 31 quarters since. The position peaked at $8.22M in Q2 2013. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

  • Dimensional Fund Advisors held 13,057 shares of Infinity Pharmaceuticals, Inc. worth $16K as of Q3 2022.
  • Dimensional Fund Advisors sold 37,775 Infinity Pharmaceuticals, Inc. shares in Q3 2022, an estimated $40.7K.
  • Infinity Pharmaceuticals, Inc. made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3472 holding.
  • Dimensional Fund Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 31 quarters since.
  • Dimensional Fund Advisors's Infinity Pharmaceuticals, Inc. position peaked at $8.22M in Q2 2013.
  • 76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.